Biomarkers and clinical trials in ALS

被引：0
|
作者：
Genge, Angela [1 ]
机构：
[1] Montreal Neurol Inst, Clin Res Unit, Montreal, PQ, Canada
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2023年 / 455卷
关键词：
D O I：
10.1016/j.jns.2023.120979
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
120979
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Use of biomarkers in ALS drug development and clinical trials
    Bakkar, Nadine
    Boehringer, Ashley
    Bowser, Robert
    [J]. BRAIN RESEARCH, 2015, 1607 : 94 - 107
  • [2] Current and emerging ALS biomarkers: utility and potential in clinical trials
    Taga, Arens
    Maragakis, Nicholas J.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (11) : 871 - 886
  • [3] Clinical Trials for Neuroprotection in ALS
    Siciliano, G.
    Carlesi, C.
    Pasquali, L.
    Piazza, S.
    Pietracupa, S.
    Fornai, F.
    Ruggieri, S.
    Murri, L.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (03) : 305 - 313
  • [4] Advances in ALS clinical trials
    Mitsumoto, H
    [J]. AMYOTROPHIC LATERAL SCLEROSIS: PROGRESS AND PERSPECTIVES IN BASIC RESEARCH AND CLINICAL APPLICATION, 1996, 1104 : 374 - 384
  • [5] Clinical trials in ALS: An overview
    Turner, MR
    Parton, MJ
    Leigh, PN
    [J]. SEMINARS IN NEUROLOGY, 2001, 21 (02) : 167 - 175
  • [6] Biomarkers Reflect ALS Clinical Courses
    Johannesen, Siw
    Baldaranov, Dobri
    Khomenko, Andrei
    Grimm, Thomas
    Kobor, Ines
    Kammermaier, Tina
    Grassinger, Jochen
    Klatt, Sabine
    Kassubek, Jan
    Deppe, Michael
    Schuirer, Gerhard
    Ludolph, Albert
    Schulte-Mattler, Wilhelm
    Premont-Schwarz, Isabeau
    Schneider, Armin
    Bruun, Tim-Henrik
    Bogdahn, Ulrich
    [J]. NEUROLOGY, 2016, 86
  • [7] Regulatory issues in ALS clinical trials
    Bryan, WW
    [J]. AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS, 2004, 5 : 36 - 41
  • [8] Clinical trials of riluzole in patients with ALS
    Miller, RG
    Bouchard, JP
    Duquette, P
    Eisen, A
    Gelinas, DF
    Harati, Y
    Munsat, TL
    Powe, L
    Rothstein, J
    Salzman, P
    Sufit, RL
    Guillet, P
    Bensimon, G
    Delumeau, JC
    Durrleman, S
    Lacomblez, L
    Leigh, PN
    Meininger, V
    Maloteaux, JM
    Delwaide, C
    Girard, M
    Masse, C
    Blin, O
    Azulay, JP
    Billeturc, F
    Pouget, J
    Bouche, P
    Camu, W
    Carlander, B
    Clanet, M
    Angibaud, G
    ArneBes, MC
    Benazet, M
    Couratier, P
    Desnuelle, C
    Lagueny, A
    Ellie, E
    Dib, M
    Rozier, A
    Salachas, F
    Viader, F
    Delaunay, D
    Dengler, R
    Guther, G
    Troger, M
    Ludolph, A
    Bachus, R
    Gericke, C
    Przuntek, H
    Langkafel, M
    [J]. NEUROLOGY, 1996, 47 (04) : S86 - S90
  • [9] What is next in ALS clinical trials?
    Sorenson, Eric J.
    [J]. NEUROLOGY, 2007, 69 (08) : 719 - 720
  • [10] CLINICAL TRIALS BASED ON BIOMARKERS
    Rosell, R.
    Moran, T.
    [J]. LUNG CANCER, 2009, 64 : S4 - S4
12345